Skip to main content
. 2023 Apr 22;47(6):706–713. doi: 10.1016/j.jgr.2023.04.006

Fig. 1.

Fig. 1

G-Rk3's effect on agonists-induced human platelet aggregation. (A) G-Rk3's effect on collagen-induced human platelet aggregation. (B) G-Rk3's effect on thrombin-induced human platelet aggregation. (C) G-Rk3's effect on U46619-induced human platelet aggregation. (D) Cytotoxicity of G-Rk3 on human platelets. The results are shown as mean ± SD (n = 4). ∗P < 0.05, ∗∗P < 0.001 in comparison to the collagen-induced platelets.